DELATESTRYL
BAUSCH HEALTH, CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is DELATESTRYL discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that DELATESTRYL 200MG has been permanently discontinued (last updated April 26, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TESTOSTERONE ENANTHATE INJECTION, USP
HIKMA CANADA LIMITED
Other Products
TESTOSTERONE ENANTHATE INJ 200MG/ML
TARO PHARMACEUTICALS INC
MALOGEX LA200 LIQ 200MG/ML
GERMIPHENE CORPORATION
PMS-TESTOSTERONE ENANTHATE INJ 200MG/ML USP
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00029246
Strength
200MG
Dosage Form
SOLUTION
Route
INTRAMUSCULAR
Active Ingredient
TESTOSTERONE ENANTHATE
Tier
Unrated
Last Updated
2024-04-26
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
DELATESTRYL has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BAUSCH HEALTH, CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.